Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quantum Health Resources was a U.S. specialty healthcare services company focused on mail-order, home-based therapies, and patient support for people with chronic and rare diseases. The company became known for serving hemophilia patients and later expanded into other genetic and chronic disorders including alpha-1 antitrypsin deficiency, primary immunodeficiency, cystic fibrosis, sickle cell disease, and Crohn's disease. Its business model centered on distribution of specialty therapies, in-home support, and disease-specific care services rather than discovery-stage drug development. Available evidence indicates the company was acquired and is no longer operating as an independent active business. It does not appear to have been a biotech drug developer with a clinical pipeline, but rather a commercial healthcare services and specialty therapy provider.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quantum Health Resources.